Abstract
Dynamic positron emission tomography (PET) imaging of the lung using the radiotracer 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18F-FDG) is an emerging method to assess noninvasively the metabolic activity of pulmonary inflammatory cells. Nevertheless, because of the distinct functional and structural characteristics of inflamed lung tissue standard methods of 18F-FDG analysis can be substantially limited and there is no consensus about the best method for quantification of the 18F-FDG signal for acute or chronic inflammatory lung diseases. This article gives an overview on recent advances in quantitative analysis of 18F-FDG uptake kinetics in non-neoplastic inflamed lung tissue.
Original language | English (US) |
---|---|
Pages (from-to) | 418-423 |
Number of pages | 6 |
Journal | Academic Radiology |
Volume | 18 |
Issue number | 4 |
DOIs | |
State | Published - Apr 2011 |
Externally published | Yes |
Keywords
- Acute respiratory distress syndrome
- Chronic obstructive pulmonary disease
- Compartmental modeling
- Cystic fibrosis
- FDG
- Lung inflammation
- Positron emission tomography
- Radionuclide imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging